News
More than one quarter of the medcines cleared by the FDA’s main review office since 2015 have been cancer drugs, a tally that ...
New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
2d
Vietnam Investment Review on MSNIBI363 earns second breakthrough therapy status for lung cancer in ChinaInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...
1don MSN
Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...
Cancer remains one of the biggest health challenges of our lifetime. Millions of people globally receive a cancer diagnosis each year — in the United States, that’s about one diagnosis every 30 ...
Updated data on IBI363 monotherapy in patients with advanced NSCLC were reported (ClinicalTrials.gov, NCT05460767). As of the ...
1d
SurvivorNet on MSNImmunotherapy For Small Cell Lung Cancer: Groundbreaking New Developments Offer Hope To PatientsFor the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...
1d
News-Medical.Net on MSNBreakthrough drug delivery system transports genetic therapies directly to the lungsScientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that ...
Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that ...
Prof Patrick Forde of the Trinity St James’s Cancer Institute presented the findings at the latest meeting of the American ...
“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...
Thanks to federally funded cancer research and clinical trials at Johns Hopkins, John Ryan has been able to attend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results